Sukumar Nagendran, President and Head of R&D: Taysha Gene Therapies TSHA Sell · Filed 01/27

Trade details

Type: Insider sale
Amount: $423,377
Shares · price: 89,132 sh · $4.75 a share
Held after: 1,344,307 sh
Stock: Taysha Gene Therapies TSHA
Person: Sukumar NagendranPresident and Head of R&D
Trade date: 26/01/23
Filed: 26/01/27
Days to filing: 4 days

Sold 6.2% of holdings

Share of holding sold: 6.2%

Taysha Gene Therapies trades, last 26 weeks

What else happened in Taysha Gene Therapies around then

Filed or reported within 30 days of the trade day · 25/12/24~02/22

Sukumar Nagendran's recent trades

Sukumar NagendranOfficer
Planned sale10b5-1 planTaysha Gene Therapies
Planned sale10b5-1 plan
Taysha Gene Therapies
TSHA
$1.3M
200,000 sh
$1.3M
Filed 07/10
Traded 07/10
Sukumar NagendranPresident and Head of R&D
Sell10b5-1 planTaysha Gene Therapies
Sell10b5-1 plan
Taysha Gene Therapies
TSHA
$892K
200,000 sh
$892K
Filed 04/13
Traded 04/10
Sukumar NagendranOfficer
Planned sale10b5-1 planTaysha Gene Therapies
Planned sale10b5-1 plan
Taysha Gene Therapies
TSHA
$926K
200,000 sh
$926K
Filed 04/10
Traded 04/10
Sukumar NagendranPresident and Head of R&D
SellTaysha Gene Therapies
Sell
Taysha Gene Therapies
TSHA
$124.1K
26,918 sh
$124.1K
Filed 01/27
Traded 01/26
Sukumar NagendranOfficer
Planned saleTaysha Gene Therapies
Planned sale
Taysha Gene Therapies
TSHA
$579.4K
113,824 sh
$579.4K
Filed 01/23
Traded 01/23

Sukumar Nagendran, President — sold $423.4K of Taysha Gene Therapies TSHA · 6.2% of holdings | Whalegun